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Background: Given the rising number of strokes worldwide, and the large number of individuals left with
disabilities after stroke, novel strategies to reduce disability, increase functions in the motor and the cognitive
domains, and improve quality of life are of major importance. Physical activity is a promising intervention to
address these challenges but, as yet, there is no study demonstrating definite outcomes. Our objective is to assess
whether additional treatment in the form of physical fitness-based training for patients early after stroke will provide
benefits in terms of functional outcomes, in particular gait speed and the Barthel Index (co-primary outcome measures)
reflecting activities of daily living (ADL). We will gather secondary functional outcomes as well as mechanistic parameters
in an exploratory approach.
Methods/Design: Our phase III randomised controlled trial will recruit 215 adults with moderate to severe limitations of
walking and ADL 5 to 45 days after stroke onset. Participants will be stratified for the prognostic variables of “centre”,
“age”, and “stroke severity”, and randomly assigned to one of two groups. The interventional group receives physical
fitness training delivered as supported or unsupported treadmill training (cardiovascular active aerobic training; five times
per week, over 4 weeks; each session 50 minutes; total of 20 additional physical fitness training sessions) in addition to
standard rehabilitation treatment. The control intervention consists of relaxation sessions (non-cardiovascular active; five
times per week week, over 4 weeks; each session 50 minutes) in addition to standard rehabilitation treatment. Co-primary
efficacy endpoints will be gait speed (in m/s, 10 m walk) and the Barthel Index (100 points total) at 3 months post-stroke,
compared to baseline measurements. Secondary outcomes include standard measures of quality of life, sleep and mood,
cognition, arm function, maximal oxygen uptake, and cardiovascular risk factors including blood pressure,
pulse, waist-to-hip ratio, markers of inflammation, immunity and the insulin-glucose pathway, lipid profile, and others.
Discussion: The goal of this endpoint-blinded, phase III randomised controlled trial is to provide evidence to guide
post-stroke physical fitness-based rehabilitation programmes, and to elucidate the mechanisms underlying this
intervention.
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General
Stroke causes substantial personal costs in terms of
disability and reduced social participation and exerts
a considerable healthcare burden on informal care
providers, healthcare providers and society in general.
Two-thirds of stroke survivors suffer from residual
neurological deficits and have to cope with chronic motor,
language and cognitive dysfunctions [1]. Persistent motor
deficits impair activities of daily living (ADL), such as
dressing, self-care, and communicating [2]. Persisting
cognitive and language deficits after stroke contribute
significantly to permanent disability and emotional
suffering in patients [3]. So far, we have limited evidence
for the effectiveness of therapies in spite of intensive
research efforts and numerous clinical trials [2].
Given the rising number of strokes worldwide [4], and the
high prevalence of disabilities after stroke, novel strategies
to reduce disability, increase functions (including communi-
cation and cognitive function), and improve quality of life
are of major importance.
Evidence for physical activity in post-stroke rehabilitation
First, animal studies have demonstrated that physical
activity enhances neural plasticity and learning, processes
central to functional recovery after stroke, by increasing
neurotrophic substances like brain-derived neurotrophic
factor, neurotransmitters such as dopamine, long-term
potentiation, and possibly even neurogenesis [5].
Second, physical therapies are known to promote
structural brain remodelling in humans [6], and this can
influence post-stroke motor deficits. A recent systematic
review indicated that repetitive practice of some com-
mon day-to-day activities lead to modest improvements
in mobility and ADL in stroke patients [7].
However, conclusive evidence for beneficial effects of
physical activity after stroke on ADL and walking speed
is still missing. Most of the studies included in the 2011
meta-analysis by Brazzelli and colleagues [8] on physical
activity-based interventions featured limited sample sizes
and had a relatively short-term follow-up. Moreover, a
variety of interventions were tested in diverse stroke
populations with a range of outcome measures. The
trials varied substantially in training intensity and
frequency, total number of sessions, timing of training
(acute, subacute or chronic), and locomotor impairment
severity (non-ambulators to community ambulators),
rendering it difficult to draw definite conclusions.
Results indicate modest treatment effects associated with
physical fitness training for stroke patients, particularly
around interventions targeting “fitness” approaches
rather than “strengthening”. Significant effects were
demonstrated for an increase in maximal oxygen uptake
and walking speed, with promising results for ADL(after intervention and on follow-up; both trends),
and quality of life (directly after intervention). However, a
subsequently published large trial on 408 stroke patients
[9], comparing treadmill-based locomotor training either
2 or 6 months post-stroke to progressive exercise at home
(non-specific, low intensity exercise intervention), did not
find a significant benefit of locomotor training with regard
to increasing the proportion of study participants who had
higher functional walking levels (comfortable walking
speed) at 1 year post-stroke. Of note, participants entered
the trial only 2 months post-stroke in an ambulatory
setting, and treadmill training was not aimed at enhancing
cardiovascular fitness.
Third, in healthy humans undergoing physical fitness
training, an increase not only in physical fitness, gait
speed, and motor function but also in cognitive functions
such as memory [10], executive functions [11], and language
learning [12] have been demonstrated. Therefore, patients
with not only motor deficits but also language and other
cognitive dysfunctions may benefit from physical fitness
training, a hypothesis that has not been addressed in most
studies.
Fourth, profound effects on mood have been demon-
strated by physical activity immediately after intervention
in stroke [13]. Therefore, mood and quality of life measures
post-stroke might be expected to improve at long-term
follow-up, possibly depending on continuation of exercise.
Fifth, post-stroke physical activity and fitness levels are
low, and these low levels are associated with common
post-stroke functional limitations [14,15]. Increased fitness
and physical function, shown to result from post-stroke
physical activity training [8,14], could benefit a range of
other common post-stroke problems by reducing fatigue,
reducing the incidence of falls and fractures, compensating
for the increased energy cost of a hemiparetic gait, reducing
disability and improving independence [14,16].
Sixth, physical fitness training is beneficial for people
with other comorbidities or risk factors for stroke.
Systematic review evidence shows that interventions
involving physical fitness training reduce blood pressure
[17], improve vascular risk factors such as obesity [18] and
type II diabetes [19], and reduce mortality in coronary heart
disease. Therefore, post-stroke cardiorespiratory training, in
particular, could reduce morbidity and mortality through
secondary prevention of stroke and comorbid conditions.
In summary, physical fitness training, delivered as
cardiovascular active, supported or unsupported ambulation
training, may benefit a range of common post-stroke
problems. It is likely that it does not simply provide a
mechanism to increase fitness and improve walking
ability, but has multiple mechanisms of action such
as enhancing neurotrophins and overall plasticity and thus
possibly exerts neuroplastic effects on motor, language and
cognitive systems [5]. Therefore, it provides a spectrum of
Figure 1 Flow diagram of the Physical fitness training in
Subacute Stroke (PHYS-STROKE) study design. PHYS-Group,
physical activity experimental intervention group; RELAX-Group,
relaxation active control intervention group.
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with stroke. However, there may also be risks, such as
training-induced vascular events, soft tissue injuries,
fatigue, altered muscle tone, and falls [20], although there
is good evidence that cardiovascular active training can be
administered successfully even in severely affected stroke
patients [8,21,22].
The need for a trial on physical activity after stroke
Physical activity may be a promising intervention to
address post-stroke functional challenges but as yet
there is no definitive study and a lack of data that can be
widely applied. With regard to previous trials [8,9], several
key questions remain to be answered. Firstly, a physical
fitness intervention starting in the early rehabilitative
phase after stroke, in an inpatient rehabilitation hospital
setting with both ambulatory and non-ambulatory stroke
patients has not been systematically assessed in a large
number of patients. Secondly, the range of possible
benefits including not only gait speed and functional
ambulation category (FAC) but also ADL, arm function,
quality of life and language as well as cognitive functions
both immediately after intervention and on follow-up
remains to be fully explored. Thirdly, an optimal physical
fitness intervention prescription for people early after
stroke has yet to be defined - for example, an intervention
that accomplishes actual active cardiovascular training.
This is an important goal: an increase in aerobic capacity
may not only improve long-term cardiovascular health
outcomes, but also promote functional abilities and
independent living (for review see [14,15]). Contemporary
stroke rehabilitation programmes [23] are generally far too
low in intensity to induce a positive training effect [16].
Objective
The objective of this study is to assess whether additional
treatment in the form of physical fitness-based training,
delivered as supported or unsupported treadmill or
electromechanical gait training, for patients early after
stroke will provide benefits in terms of outcomes that
reflect their daily living - in particular gait speed and the
Barthel Index (BI), a measure of ADL (co-primary outcome
measures), both immediately after the intervention, 3 months
(after stroke onset) (primary outcome), and at medium-term
(6 months) follow-up. Using an exploratory approach
we will also gather data on arm function, quality of life,




This is a multi-site, two-arm, endpoint-blinded, phase III
randomised controlled trial comparing 4 weeks physical
fitness training in addition to standard rehabilitationtreatment (experimental intervention) versus 4 weeks
relaxation treatment in addition to standard rehabilitation
treatment (active control intervention). The primary
outcomes will be gait speed (in m/s, 10 m walk) and ADL
(as measured by the BI) 3 months after stroke (co-primary
endpoints). For study design, see Figure 1.
Study enrolment
Individuals post-stroke aged 18 years or older are recruited
5 to 45 days post-stroke at six clinical sites (inpatient
rehabilitation hospitals in or around Berlin).
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All patients entering the six rehabilitation hospitals with
the primary diagnosis of stroke [24] will be entered into
a screening log by the designated trial physician of the
respective site. Subsequently, the patient will be screened
for eligibility with the inclusion and exclusion criteria
as outlined below (see also Table 1). Eligible patients
will be fully informed of the study, and a patient
screening identification number will be assigned to
the patient. Patients are then asked to provide
informed consent (see below). The screening process
allows us to determine the number of eligible patients.
In the event that a potential participant does not
meet the inclusion criteria, no identifiable information
is retained on that participant. Reasons for exclusion
will be reported.
Subsequently, the designated trial physician will record
all baseline medical and neurological information in the
case report form. One of the designated study assessors
will be assigned to the patient, and conduct all baseline
assessments (see “Study outcome assessment” and Table 2)
at the respective rehabilitation centre. The study assessor
is part of the study team and will not be involved withTable 1 Inclusion and exclusion criteria of Physical fitness tra
Inclusion criteria
1. Diagnosis of stroke (within 5–45 days after stroke); ischaemic or haemo
MRI/CT scan of the brain)
2. Age ≥18 years
3. Able to sit for at least 30 seconds (unsupported or supported - that is, h
4. Barthel Index ≤65 at inclusion
5. Considered able to perform aerobic exercise, as determined by respons
6. Provision of written informed consent
Exclusion criteria
1. Patient considered unable to comply with study requirements
2. Stroke due to intracranial haemorrhage primarily due to bleeding from
3. Progressive stroke
4. Unable to perform the required exercises due to a) medical, b) musculo
4a. medical problems: unstable cardiovascular condition, or other serious c
Association Class IV criteria, hospitalisation for myocardial infarction or h
serious and unstable cardiac arrhythmias)
4b. musculo-skeletal problems: restricted passive range of motion in the m
hip or knee joints, or a dorsiflexion deficit of >20° for the affected ankle
4c. neurological problems: severity of stroke-related deficits
5. Required help of at least 1 person to walk before stroke due to neurolo
sclerosis, multiple sclerosis) or non-neurological (for example, heart failu
6. With life expectancy of less than 1 year as determined by responsible p
7. Drug or alcohol addiction within the last 6 months
8. Significant current psychiatric illness defined as affective disorder unresp
schizophrenia or suicidality
9. Current participation in another interventional trial
CT, computer tomography; MRI, magnetic resonance imaging.treatment of patients or with administration of the inter-
vention, and will remain fully blinded to the patient’s
group allocation throughout the trial.Informed consent
Written informed consent for study participation is
obtained at 5 to 45 days post-stroke (see above).
Participants are informed that successful completion
of the baseline tests is required prior to randomisation to
an intervention group.Inclusion and exclusion criteria
Participants are individuals with recent onset of ischaemic
or haemorrhagic stroke. For purposes of inclusion in this
study, a stroke is defined according to the World Health
Organization definition as “a rapid onset event of vascular
origin reflecting a focal disturbance of cerebral function,
excluding isolated impairments of higher function and
persisting longer than 24 hours” [24]. Stroke diagnosis
is confirmed by computed tomography or magnetic
resonance imaging scan (for details see Table 1).ining in Subacute Stroke (PHYS-STROKE) study
rrhagic (cortical, subcortical, brainstem), as determined by initial
olding onto supports such as the edge of the bed)
ible physician
ruptured aneurysm or arteriovenous malformation
-skeletal, or c) neurological problems (for details see below, 4a-c)
ardiac conditions (for example, anyone meeting New York Heart
eart surgery within 120 days, severe cardiomyopathy or documented
ajor lower limb joints (that is, an extension deficit of >20° for the affected
)
gical (for example, advanced Parkinson’s disease, amyotrophic lateral
re, orthopaedic problems) co-morbidities
hysician
onsive to medication or bipolar affective disorder, psychosis,
Table 2 Study outcome assessment
Baseline End of intervention Follow-up (3 months) Follow-up (6 months)
Primary outcome (co-primary)
Gait speed (in m/s, 10 m walk) X X
Barthel Index X X
Secondary outcome
Gait speed (in m/s, 10 m walk) X X
Barthel Index X X
Mobility
Gait endurance (6-minute walk) X X X X
Actigraph X X X X
Rivermead mobility index X X X X
Motor function
Rivermead arm test X X X X
Box and block test X X X X
REPAS scale X X X X
Medical research council scale X X X X
Functional ambulation classification X X X X
Cognitive function
Montreal cognitive assessment X X X X
Trail Making test A and B X X X X
Semantic and phonemic word fluency X X X X
Disability, quality of life, sleep, mood
Modified rankin scale X X X X
EQ-5D-5 L X X X X
Pittsburgh sleep quality index X X X X
CES-D scale X X X X
Physical fitness
Maximal oxygen uptake and gait energy expenditure X X X X
Cardiovascular risk factors, others
Systolic/diastolic blood pressure, heart rate X X X X
Weight X
Waist-to-hip-ratio X X X X
Laboratory tests (blood draw) X X X X
Hair cortisol concentration (strand of hair) X
CES-D Scale, Center for Epidemiological Studies Depression Scale; EQ-5D-5 L, Euro Quality of Life 5 Dimension 5 Level scale; REPAS scale, REsistance to PASsive
movement Scale.
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Methods and timing of assessments
Measures selected have established reliability and
validity and are performed according to standardised
protocols defined in an operations manual. Blinded study
assessors conduct all baseline and follow-up assessments
(after 4 weeks intervention, 3 and 6 months post-stroke).
Participants are instructed after randomisation to refrain
from discussing assignment group during evaluations. In
addition, a reminder card is handed to each patient at thebeginning of each evaluation session to remind them
not to reveal their group assignment. To determine the
effectiveness of our blinding strategy, the study assessor will
be asked if they were or were not “unblinded”. In addition,
during the intervention all additional therapy sessions are
recorded (for details, see “Additional information” below).
Cerebral blood flow and volume, functional and structural
networks (based on magnetic resonance imaging) as well as
blood biomarkers of endothelial function will be determined
in a subgroup of patients at baseline and at the end of the
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Identifier NCT01954797).
Measures
Primary efficacy endpoints (co-primary endpoints)
Co-primary endpoints are change in gait speed (in m/s,
10 m walk) and BI (100 points total) at 3 months post-stroke
compared to baseline measurements. Co-primary endpoints
are chosen so that a comprehensive picture of the treatment
effect can be obtained [25]. Because each primary endpoint
can characterise a clinically meaningful benefit of the
intervention on its own, we use the “or decision rule”,
meaning that the study is regarded as successful in
case that one of the two primary endpoints improves
significantly in the intervention group.
BI is chosen as one of the primary outcome measures
since it assesses disability, and improving disability is a
primary goal of physical therapy interventions post-stroke.
BI is largely based on mobility, which will be targeted by
treadmill-based physical fitness training. Additionally, BI
is widely used in the rehabilitative setting in Germany and
is the primary parameter for allocation to rehabilitation
facilities by healthcare insurers. A relatively large trial [22]
demonstrated that treadmill training may significantly
enhance BI scores in a cohort of severely affected
patients in a subacute inpatient rehabilitation setting.
We acknowledge concerns about the ceiling effect of
BI but, given the severity of disability at baseline in our
patient population, we consider the risk of it masking a
positive effect of the intervention to be minimal and
acceptable. The inclusion criteria specify “BI at baseline ≤65
points”. A difference of 10 points of the BI is considered a
clinically meaningful difference [26].
Gait speed is chosen because it is related to the severity
of impairment in the home and the community, and
functional walking capacity is a primary goal of many
physical therapy interventions post-stroke. Moreover,
previous studies in post-stroke patients that involved
treadmill-based physical fitness training have most
often used gait-related primary outcome measures [8,9].
Gait speed (m/s) will be assessed with the 10-m test: the
patients will walk a distance of 14 m (2 m for acceleration
and deceleration) at their maximum speed twice. The time
will be taken and the mean speed (m/s) calculated
[22,27,28]. A difference of 0.1 m/s on short distance walks
(for example, ambulation around the house) is considered
a clinically meaningful difference [29,30].
Key secondary endpoints
Change in gait speed and BI at the end of intervention
and at 6 months post-stroke, compared to baseline gait
speed and BI, will constitute secondary endpoints.
Additional secondary endpoints, to be assessed at baseline,
end of intervention, and 3 and 6 months post-stroke includethe following (see also Table 2 and Additional file 1):
mobility (gait endurance, Actigraph, Rivermead Mobility
Index), motor function and spasticity (Rivermead Arm
Test, Box and Block Test, Medical Research Council scale,
REsistance to PASsive movement scale), cognition
(Montreal Cognitive Assessment, Trail Making Test A
and B, Semantic and Phonemic Word Fluency), disability,
mood and quality of life (Euro Quality of Life 5 Dimension
5 Level scale, Pittsburgh Sleep Quality Index, Center for
Epidemiological Studies Depression scale, modified
Rankin scale), and physical fitness (maximal oxygen uptake,
gait energy expenditure).
Moreover, we will assess total time spent in physical activ-
ity per day (usual care intervention log; by physiotherapist),
FAC, vascular risk factors (resting systolic and diastolic
blood pressure; resting heart rate; body mass index,
waist-to-hip ratio, markers of inflammation, immunity
and the insulin-glucose pathway, lipid profile, and
other laboratory parameters, derived by a blood draw
from a peripheral vein, hair cortisol concentration by
taking a small strand of hair [31]), length of time in
rehabilitation, and medication.
For more details, see Additional file 1.Assessment of safety
At each assessment (baseline, end of intervention, and 3
and 6 months post-stroke), the following parameters will
be systematically recorded: recurrent fatal or non-fatal
cardiovascular or cerebrovascular events; referral to an
acute hospital; death.
After each intervention, the physiotherapist will record
the presence of self-reported pain, fatigue, dizziness,
number and nature of falls, and note other adverse events.Additional information
Total time spent in rehabilitative therapies will be
recorded by usual care intervention logs to track the
amount of physical, occupational, speech and language,
and cognitive therapy that Physical fitness training in
Subacute Stroke (PHYS-STROKE) participants receive
during enrolment in the trial as part of the usual care
treatment. Therapists (during inpatient treatment, both
during the trial intervention and beyond) and patients
(in the months following inpatient rehabilitation) are
instructed to write in the time (in minutes) of additional
therapy they receive outside of their participation in the
trial on monthly calendars provided for them. The
patients will return the monthly calendar to the study
assessor during follow-up visits.
Information on the medications taken by a participant
is recorded at baseline and at the follow-up assessments.
Length of time (in days) spent in rehabilitation will also
be recorded.
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Standardisation of data collection methods is achieved
through a systematic training and competency assessment
programme for the blinded assessors. The assessors are
informed of the battery of outcome measures in a lecture
and demonstration. This is followed by practice on
volunteers (usually persons with stroke) under the
supervision of the study’s clinical research coordinators
and site team leaders, and successful completion of
competency training confirmed by a competency check-list.
Randomisation
Each participant is assigned to one of two groups, either the
physical activity (PHYS) group or the relaxation (RELAX)
group by block-randomisation with stratification for centre,
age (≤65 years, >65 years), and severity (functional
ambulation category, FAC (0–3, 4–5)). Age and severity
might influence functional outcome, and will therefore be
included as stratification factors. Moreover, given the
pragmatic approach for the application of physical fitness
training, and given that different physiotherapists will
administer the training in each rehabilitation site, the study
centre will be another stratification factor.
The allocation of patients to the two groups (PHYS or
RELAX group) will be conducted online by using the
web-based randomisation tool of the Institute of Medical
Informatics, statistics and documentation, Medical University
of Graz, Austria; available at http://www.randomizer.at.
Interventions
Participants are randomised to one of two intervention
groups, each receiving five treatment sessions per week for
4 weeks (total of 20 sessions): 1) PHYS (physical activity
group; target intervention); or 2) RELAX (relaxation group;
control intervention).
Both target and control groups will receive any prescribed
usual and customary rehabilitative care during the 4 weeks
in addition to the PHYS and RELAX interventions.
Customary rehabilitative care may involve cardiovascular
active training. However, little cardiovascular active
training is actually administered during the course of
the normal rehabilitation programme (see our on-site
pilot study; see also [16] for review). The fitness training
in the target group will always be in addition to the
normal rehabilitation programme. The reason to allow
individuals to receive usual and customary rehabilitative
care is that participants may be reluctant to enrol if they
believe trial participation will reduce their opportunities
to participate in other therapy. Usual care interventions
are monitored by usual care intervention logs.
PHYS training programme
Physical fitness training (cardiovascular active; 50 to 60%
of maximum heart rate) [32] will be delivered as supportedor unsupported treadmill training or on an electro-
mechanical gait trainer. To be cardiovascular active
(that is, reaching training intensities of 50 to 60% of
maximum heart rate; 180 beats per minute, Gordon and
colleagues [21]), target heart rate will be determined
according to the following formula: 180 – age. In case of a
beta blocker medication, 10 beats will be subtracted; that
is 180 – age – 10 = target heart rate (pragmatic approach;
see [21,33]).
A graded increase of belt speed, reduction of body
weight support and/or inclination will be used to elicit
adequate cardiovascular stress to induce an aerobic
training effect. During aerobic training, patients will
wear a modified parachute harness to prevent falls. The
body weight will be either unsupported or supported to a
maximum of 15% of body weight according to individual
needs. If necessary, one or two therapists will provide help
with setting the paretic limb or assisting weight-shifting,
and hip and knee extension.
Each session will start with a warm-up of 3 minutes,
followed by 20 minutes exercise at target heart rate, and
2 minutes cool-down. If the patient indicates that they
need to rest, or the therapist decides that rest is needed
(heart rate; overall impression), a maximal 2-minute rest
period (sitting) will be allowed, followed by a return to
training heart rate over 1 to 2 minutes. Goals for each
session address achieving cardiovascular active training
duration of 20 minutes, and maximal body weight load
while maintaining the kinematics and posture associated
with walking. An early training priority is to achieve an
upright symmetrical posture with spatial-temporal symmetry
of the stepping pattern. Initially, the participant may
walk with a shorter step length for the non-paretic
limb and the step centred in the middle of the treadmill as
a means to compensate for deficits in paretic limb and
trunk control. A trainer thus initially works with the
participant to verbally cue or manually assist with foot
placement of the non-paretic limb.
RELAX training programme
Relaxation sessions will avoid cardiovascular active activity
and aim for <30% of maximum heart rate [32]. Relaxation
sessions will involve the relaxing of different muscle
groups over the face, head, shoulders, arms, legs, chest,
back, and abdomen, guided by the therapist and compact
disc. With eyes closed and in a sequential pattern, the
patient is encouraged to concentrate on the sensation of
relaxation such as feelings of warmth and heaviness. This
progressive training helps the participant achieve physical
and mental relaxation and calmness [34], and does
not convey any cardiovascular active training, but the
same amount of additional contact by the therapist.
Cardiovascular response monitoring during the RELAX
intervention is identical to that done in the PHYS group.
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control for the Hawthorne effect, but exclusively
through interventions that have been shown to have
little or no impact on aerobic exercise capacity. Each
participant is individually progressed according to their
ability within each phase..
Vital signs monitoring for PHYS and RELAX interventions
Blood pressure, heart rate and Borg scale Rate of
Perceived Exertion will be monitored prior to a session
and at the completion of each session. Heart rate will be
monitored during each session. Heart rate must be less
than 100 beats per minute to begin the training session.
Resting diastolic blood pressure must be <100 mmHg and
systolic blood pressure <180 mmHg to begin the training
session [35]. The American College of Sports Medicine
criteria for terminating an inpatient exercise session are
followed according to guidelines shown to be effective
for persons post-stroke with multiple comorbidities [35].
If the patient complains of angina at rest, loss of
consciousness occurs, or cardiac arrest, emergency
medical services are called immediately. All trainers
are cardiopulmonary resuscitation certified and aware
of signs of cardiac complications.
Standardisation for the interventions
The PHYS and RELAX interventions are standardised to
achieve consistent implementation of the intervention
across rehabilitation sites. Standardisation assures that
the training teams successfully implement a common
intervention through application of six critical elements:
1) knowledge of the protocol; 2) goal setting, decision-
making and progression; 3) participant safety and
monitoring; 4) equipment use; 5) hands-on training skills;
and 6) participant’s role and participation.
Documentation procedures are standardised across
sites and require trainers to record in a computerised
database all training parameters. A competency-based
training programme will be used to train the trainers
across all sites. The intervention teams will meet for
a 2-day training course, return to their clinical sites
for 1 month of pilot training, with follow-up sessions
at each of the six sites to complete competency-based
training and testing. Competency is required in each of
the six knowledge and application domains and includes
both written and practical components.
After individual therapists and the site achieve competency
status, they are approved to train patients in the randomised
controlled trial. Competency status is maintained throughout
the trial by each site and is regularly reviewed by the study
team. Turnover in therapists across sites is anticipated
across a 2.5 year span of participant entry and training. The
intervention site team leader is responsible for training new
staff. The therapist must achieve intervention competencybefore joining the site team in treating patients. Any
deviation from established competency standards requires
immediate retraining and re-evaluation. No therapist is
allowed to conduct treatment without established and
maintained competency.
The Clinical Research Coordinator and co-primary
investigators are responsible for maintaining standardisation
and competency throughout the trial. Communication
between clinical research coordinators, co-primary
investigators and centre representatives is maintained
through weekly conference calls. A web-based discussion
board specific to each intervention provides timely
responses to questions from the training teams with
responses available to all training personnel. This list
of questions and responses is recorded throughout
the trial and used to refine or clarify the training
manual. The Clinical Research Coordinators conduct
weekly to bi-monthly visits to each site and relay any
intervention-related concerns to the primary investigators.
Finally, the investigators have prepared an intervention
training manual for therapists available at each clinical site.
Statistical analysis
The following power calculation estimates the number
of participants required for given primary outcomes and
estimates of power. PHYS-STROKE is powered to detect
a difference in gait speed of 0.13 m/s, and a difference in
Barthel Index of 10 points between the two groups. A
total of 172 patients (86 patients per group) will enter
this study. Because of the analysis of two primary
outcomes, the significance level was Bonferroni-corrected
(α = 0.05/2 = 0.025).
First co-primary endpoint: change in BI at 3 months
follow-up compared to baseline. We took a German
“repetitive locomotor therapy” study (20 minutes on gait
trainer + 25 minutes physiotherapy per day five times
per week for 4 weeks) [22] as the basis for the power
calculation for the outcomes measured on the BI. A
difference of 10 points on the BI is considered a
clinically meaningful difference [26]. With a power of
80%, PHYS-STROKE will detect a group difference at a
two-sided 0.025 significance level, if the mean difference
of improvement on the BI between groups is 10 points if
86 patients in each group will be included. This is based
on the assumption that the common standard deviation of
the response variable is 21 (at 3 month follow-up).
Second co-primary endpoint: change in gait speed at
3 months follow-up. A difference of 0.1 m/s on short
distance walks is considered a clinically meaningful
difference [29,30]. A sample size of 86 in each group
will have 87% power to detect a difference between
groups in means of improvement in gait speed of
0.13 m/s (mean improvement in intervention group
of 0.31 m/s and mean improvement in control group
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deviation is 0.25 using a two group t-test with a
0.025 two-sided significance level.
Drop out was estimated at 25%, resulting in a trial
with a total of 215 subjects. This is considered feasible
for the six large recruiting centres over a period of
2.5 years recruitment.
Group differences for the co-primary endpoints will be
analysed using analysis of covariance (ANCOVA) with
baseline measures as covariates.
Here, the t-test was used for sample size estimation in
spite of the intended analysis with an ANCOVA model.
It can be shown [36] that this is a conservative approach
for estimating samples sizes for ANCOVAS, because an
ANCOVA with (1 – p2)*n subjects has the same power
as a t-test with n subjects where p is the variance
deflation factor, calculated by the correlation of baseline
and follow-up measures. Assuming the worst case of p = 0
leads to the sample size based on the t-test.
Analysis plan
The analyses of primary and secondary endpoints will be
performed in the intention-to-treat population consisting
of all randomised patients who received at least 1 day
of training. In patients lost to follow-up, their last
observation will be carried forward in order to accomplish
the intention-to-treat analysis.
The primary analysis will apply an ANCOVA with the
two primary outcomes at follow-up as dependent variables,
and baseline scores and group as independent variables.
Additionally, the analysis will be adjusted for centre, age
and severity (as assessed by the FAC) of stroke.
As a worst case sensitivity analysis, the primary analysis
will be repeated by imputing baseline values for missing
values instead of last observation carried forward. Regarding
the secondary endpoints, results from the study will be
analysed using standard statistical methods. For every
endpoint it has to be checked in advance which covariates
should be accounted for, and this will not be presented in
detail here. Limitations resulting from the study design, the
sample size or unmeasured confounders will be discussed.
No adjustment for multiplicity of testing is provided.
No interim analysis (other than a blinded sample size
reassessment) is planned since the follow-up time is
long as compared to the anticipated recruitment time.
A fully specified statistical analysis plan will be written
before unblinding of the study. The final report of the trial
will follow the CONSORT extension for non-drug trials.
Avoidance of missing data
To limit missing data as much as possible, we have
implemented the following steps. Participating sites
and their primary investigators have been chosen from
within the framework of the Berlin Stroke Alliance, analliance of stroke care providers and researchers that has
been set up in Berlin and Brandenburg and will allow us
to recruit, treat and perform long-term follow-up on a suf-
ficiently high number of stroke patients in a high-quality
neurorehabilitation trial. All participating sites have worked
together for several years, for example, to develop a core
data set of the Berlin Stroke Alliance [37]. All sites
participated in the set-up of the trial during several
meetings over the last year, in which the participation
of physiotherapy and nursing staff was ensured.
Agreements between the central study centre and the
sites with regard to basic trial equipment and case
payments (considering missing data and drop-outs)
have been concluded. Moreover, a questionnaire was
sent to each site to evaluate the annual number of chronic
stroke patients potentially available for the trial in that
site, the clinical spectrum of patients, available experience
with clinical trials and other currently competing studies.
Investigators and study staff are trained on the importance
of keeping participants in the trial until the end, regardless
of whether they continue to receive the assigned treatment,
and this information is also conveyed to study participants.
Even if a patient wishes to discontinue study treatment, all
reasonable efforts will be made to obtain the patients’
informed consent for the collection of at least primary
outcome data. Contact information for participants is kept
up to date in order to prevent loss to follow-up. Moreover,
physiotherapists delivering the intervention (target and
control) are trained in providing a positive experience,
and the amount of data collected by the trial assessors has
been restricted as much as possible. Both patients and
their relatives/care-givers will be provided with detailed
and updated information on the background and purpose
of the trial, to keep motivation to continue with the
intervention and follow-ups as high as possible.
The on-site monitor will pay particular attention to
missing data during the process of source data verification
and the study centre will provide with further training if
necessary. Furthermore, regular communication with the
study community (for example, by study newsletter) is
planned by the central study centre to ensure the profile
and interest in the study is maintained.
Handling of drop-outs/missing data
For patients that are not willing or able to complete
their intervention (at least 75% of the intended training/
relaxation sessions) but do not retract their informed
consent, the co-primary endpoints gait speed and BI
will be assessed after their last intervention, and at
3 months follow-up. Using the 3-month follow-up
values, an intention-to-treat analysis will be possible.
For those patients who drop out and are not willing to be
assessed regarding gait speed and BI after 3 months, we
will use adjusted regression-based multiple imputation
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impute missing values and we will analyse both the
full data set with imputed values and the smaller data
set without imputed values in an intention-to-treat
analysis [38,39].
Adverse event monitoring and reporting
Adverse events are carefully monitored at every level of the
PHYS-STROKE trial. A Data Safety Monitoring Board
provides oversight and meets after randomisation of
every 50 new patients. All adverse events are reported
immediately to the responsible physician and the board
members are informed of all serious adverse events.
For more details on data management, quality control
and study organisation, see Additional file 1, sections enti-
tled “Data Management and Quality Control Procedures”
and “Study Organisation and Management”.
Ethics
All procedures conducted during this trial will be carried
out in compliance with institutional ethical standards
and in compliance with the Declaration of Helsinki. All
research procedures were approved by the responsible
Institutional Review Boards (for more details, see Add-
itional file 2).
Dissemination policy
Trial results will be published first in scientific journals.
Moreover, results will be made available for a scientific
and a lay audience on the ClinicalTrials.gov website
(Registered in ClinicalTrials.gov with the Identifier
NCT01953549) [40]. As part of the Cochrane Collaboration
Initiative, full access will be granted to the protocol,
participant-level data set and statistical code, for future
reviews for published data and individual patient data
meta-analysis. Authorship will follow the “Uniform
Requirements for Manuscripts Submitted to Biomedical
Journals: Ethical Considerations in the Conduct and
Reporting of Research: Authorship and Contributorship”,
for details see http://www.icmje.org/ethical_1author.html.
No professional writers will be employed.
Discussion
This multi-site, randomised controlled trial is designed to
determine the impact of cardiovascular active early physical
fitness intervention, compared to a relaxation control
condition, on clinically and functionally meaningful changes
in ability and function for patients after stroke.
Considering the lack of knowledge with regard to
evidence-based care, and the high level of medical interest
in the area of rehabilitation and of physical activity after
stroke, this trial will present a significant advance in clinical
knowledge about physical fitness intervention after stroke.This trial will make several unique contributions to the
practice of cardiovascular active fitness therapy after stroke.
Firstly, we will answer the question whether physical fitness
intervention starting in the early rehabilitative phase after
stroke will benefit their daily living - in particular in terms
of gait speed and the BI. Secondly, we will provide
first-time ever information on the effects of physical
fitness intervention on language and cognitive function
after stroke, and add further evidence to its effect on quality
of life measures. Thirdly, we will help define an optimal
physical fitness intervention prescription for people early
after stroke. Given the wide availability of treadmill devices
in rehabilitation settings across the world, the intervention
would be transferable to inpatient (for example, Germany,
Switzerland, Austria) and outpatient (for example, UK,
USA) rehabilitation settings in the future. Fourthly,
we will provide unique information about the mechanisms
underlying physical fitness intervention, including laboratory
markers of inflammation and the insulin-glucose pathway
as well as markers of cerebral vasculature as well as
functional and structural networks.
Trial status
Patient recruitment will start in October 2013 and is
aimed to continue for 30 months in total. Last follow-up
is scheduled for October 2016.
Additional files
Additional file 1: Description and rationale for secondary outcome
measures, data management and quality control procedures, and
study organisation and management.
Additional file 2: List of participating institutions, principal local
investigators and ethical body responsible for the respective centre.
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